Hoya

Corporate brand

Japanese global med-tech and precision-technology group specializing in ophthalmic products, medical systems, semiconductor photomasks, data-storage substrates, and optical components.

Last updated November 4, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

HOYA Corporation is a Japanese multinational technology and med-tech company whose businesses span eye health, medical devices, semiconductor manufacturing materials, data-storage components, imaging products, and specialized software. The company began in 1941 when brothers Shoichi and Shigeru Yamanaka established an optical-glass plant in Hoya, Tokyo. It was incorporated in 1944 and initially developed optical glass, crystal products, and other precision-manufactured materials. Over subsequent decades, HOYA expanded from a traditional optical manufacturer into a diversified group built around materials science, optical design, molding, polishing, coating, precision manufacturing, and specialized production technologies. Today, HOYA organizes its activities primarily into two broad businesses: Life Care and Information Technology. Life Care includes prescription eyeglass lenses, contact lenses and contact-lens retailing, intraocular lenses for cataract surgery, flexible medical endoscopes, endoscope-related equipment, artificial bones, surgical instruments, disinfection systems, chromatography media, and other medical products. The Information Technology business supplies high-value components used in semiconductor fabrication, flat-panel-display manufacturing, hard-disk drives, and imaging systems. Its semiconductor-related portfolio includes photomask blanks and photomasks used in advanced lithography, including products supporting extreme ultraviolet semiconductor production. Its data-storage activities include glass disks and substrates for hard-disk drives, while its imaging activities include optical components and photographic products. A major strategic turning point came through the integration of Pentax. HOYA pursued Pentax principally to strengthen its healthcare and medical-technology position, especially in flexible endoscopy, intraocular lenses, surgical visualization, and related optical technologies. HOYA completed a successful takeover in 2007, and Pentax merged into HOYA in March 2008. The transaction added the PENTAX Medical business and expanded HOYA's medical capabilities, while the acquired camera and surveying businesses were later divested. HOYA sold the Pentax camera business to Ricoh in 2011 and had previously transferred the surveying-instrument business to Taiwan Instrument in 2009. The company has also used acquisitions and portfolio management to extend its reach. Examples include the purchase of ReadSpeaker in 2017, adding cloud-based text-to-speech technology; the acquisition of Performance Optics, including VISION EASE and Daemyung Optical-related operations, to expand ophthalmic lenses; the purchase of C2 Therapeutics to broaden interventional endoscopy; and the acquisition of Optotal Hoya in Brazil to deepen direct access to the Latin American prescription-lens market. In 2025, HOYA announced that it would transfer its voice-synthetic software operations, including ReadSpeaker entities, to Marunouchi Capital, reflecting a decision to concentrate management resources on businesses more central to its portfolio. HOYA's consumer-facing and professional offerings include high-index, progressive, photochromic, and specialty eyeglass lenses; contact lenses and the Eyecity retail chain; Vivinex intraocular lenses and multiSert injectors; PENTAX Medical endoscopy systems; MiYOSMART myopia-management lenses; semiconductor photomask blanks; hard-disk-drive glass substrates; and optical components. MiYOSMART, introduced in selected markets in 2018, uses Defocus Incorporated Multiple Segments technology and is designed to slow myopia progression in children. Availability and regulatory status vary by country. The company remains a public, internationally operating enterprise headquartered in Tokyo. Its current strategy emphasizes a dual-engine portfolio: Life Care provides exposure to structural trends such as population aging, cataract treatment, and rising myopia, while Information Technology benefits from semiconductor miniaturization, data growth, and demand for precision components. HOYA's management approach gives substantial autonomy to business divisions while using periodic portfolio reviews, capital allocation, research and development, production-capacity investment, and selective bolt-on acquisitions to balance growth, profitability, and resilience.

History

HOYA's history began in November 1941, when brothers Shoichi and Shigeru Yamanaka established an optical-glass production plant in Hoya, Tokyo. The business was incorporated in 1944 and initially concentrated on optical glass and related precision materials. In the immediate postwar period it added crystal products, demonstrating an early willingness to apply its glass-processing capabilities beyond its original niche. HOYA listed on the Second Section of the Tokyo Stock Exchange in 1961, marking an important step in its development as a public Japanese manufacturer. During the 1960s and 1970s, HOYA broadened its optical and ophthalmic activities. It began producing eyeglass lenses in 1962 and soft contact lenses in 1972. In 1975, it developed and started producing semiconductor photomask blanks, establishing an important connection between optical materials and the electronics industry. This move was strategically significant because photomask blanks became essential to the manufacture of integrated circuits and later advanced semiconductor devices. The company continued to diversify in the 1980s and 1990s. It introduced or developed technologies for aspherical molded lenses, intraocular lenses, hard-disk-drive glass disks, and other optical and electronic components. Production of glass disks for hard-disk drives began in 1991. HOYA also built capabilities in optical design, molding, polishing, coatings, and precision surface processing. These competencies allowed it to serve both healthcare markets and highly demanding industrial customers. In the early 2000s, HOYA expanded its ophthalmic and electronic portfolios. It launched soft intraocular lenses in 2001 and introduced increasingly sophisticated progressive-lens technologies. Its electronics-related products benefited from the rapid growth of digital consumer electronics and data storage. In 2007, HOYA acquired Performance Optics, strengthening its position in prescription ophthalmic lenses and adding businesses associated with VISION EASE and related optical products. The most consequential corporate event of the period was the integration of Pentax. HOYA and Pentax initially discussed a management integration in 2006 and 2007, with HOYA seeking to strengthen its medical business through Pentax's endoscopy, intraocular-lens, surgical-loupe, and biocompatible-material technologies. HOYA completed a friendly takeover bid in August 2007, acquiring more than 90 percent of Pentax. Pentax subsequently merged into HOYA on March 31, 2008. The transaction added PENTAX Medical and broadened HOYA's presence in flexible endoscopy and related healthcare fields, while also bringing camera, lens-module, surveying, and speech-synthesis activities into the group. HOYA subsequently reshaped the acquired portfolio. The Pentax surveying-instrument business was sold to Taiwan Instrument in 2009, and the crystal business was discontinued. HOYA transferred its HDD glass-disk media business and related assets in 2010. In 2011, it sold the PENTAX Imaging Systems business to Ricoh, while retaining the medical endoscopy, artificial-bone, and speech-synthesis activities inherited through the merger. This period established a recurring pattern in HOYA's strategy: acquire capabilities that reinforce optical and healthcare expertise, then divest activities that do not fit the preferred portfolio. During the 2010s, HOYA expanded internationally through acquisitions and operating partnerships. It bought Optotal Hoya in Brazil in 2012, converting a long-standing distribution and manufacturing relationship into a more direct presence in the country's prescription-lens market. It acquired or invested in businesses connected with medical endoscopy, ophthalmic lenses, and specialty medical devices. In 2017, HOYA acquired ReadSpeaker, adding a global cloud-based text-to-speech business to its portfolio. That same year, it expanded its ophthalmic-lens position through the acquisition of Performance Optics and continued to develop PENTAX Medical through new products and partnerships. HOYA also developed MiYOSMART through research conducted with the Hong Kong Polytechnic University. The company began work on spectacle-lens approaches to myopia management in 2012 and launched MiYOSMART in selected markets in 2018. The product uses Defocus Incorporated Multiple Segments technology and was designed to slow the progression of childhood myopia. Its expansion has been subject to country-specific regulatory approvals and market availability. In the 2020s, HOYA increasingly described itself as a global med-tech and high-technology group organized around Life Care and Information Technology. The Life Care portfolio benefits from structural trends including aging populations, cataract surgery, rising myopia, and demand for minimally invasive diagnosis. The Information Technology portfolio serves semiconductor miniaturization, flat-panel displays, imaging, and data-storage markets. A cyberattack detected on March 30, 2024 temporarily disrupted manufacturing and order-processing systems, prompting HOYA to review and strengthen its IT-security infrastructure. In 2025, HOYA adopted a new progressive-dividend policy with a target payout ratio of 40 percent. It also announced the transfer of its voice-synthesis business, including ReadSpeaker entities, to a special-purpose company operated by Marunouchi Capital. The transaction reflected a portfolio decision to concentrate group resources on businesses considered more strategically central. In 2026, HOYA announced a strategic review of its medical endoscope business, including the possibility of a third-party transfer, although it stated that no specific transaction had been decided. Through these developments, the company continues to combine long-term investment in optical and medical technologies with active portfolio management.

2026
Medical endoscope strategic review launched
[13]HOYA: Medical endoscope strategic reviewssl4.eir-parts.net
HOYA began reviewing strategic alternatives for the global PENTAX Medical endoscope business.
2025
Progressive dividend policy adopted
[16]Progressive dividend policy adoptedhoya.com
HOYA announced a progressive dividend policy with a target payout ratio of 40 percent.
2025
Voice-synthesis business transfer announced
[12]HOYA: Voice-synthesis business transferssl4.eir-parts.net
HOYA announced the transfer of its ReadSpeaker-related voice-synthesis operations to a Marunouchi Capital special-purpose company.
2024
Cyberattack disrupted company systems
[8]HOYA Report 2024: Cyberattack disclosurehoya.com
A cyberattack temporarily affected manufacturing, order processing, and other systems across multiple business units.
2018
MiYOSMART launched in selected markets
[15]MiYOSMART launched in selected marketshoya.com
HOYA introduced MiYOSMART myopia-management spectacle lenses using D.I.M.S. technology.
2017
ReadSpeaker acquired
[9]HOYA: ReadSpeaker acquisition announcementhoya.com
HOYA acquired ReadSpeaker, expanding its text-to-speech and voice-synthesis operations.
2012
Optotal Hoya in Brazil acquired
[11]HOYA: Optotal Hoya acquisitionhoya.com
HOYA acquired its Brazilian prescription-lens partner to strengthen direct presence in South America.
2011
PENTAX Imaging Systems sold to Ricoh
[10]HOYA: PENTAX Imaging Systems salehoya.com
HOYA transferred the camera and imaging business inherited from Pentax to Ricoh.
2008
Pentax merged into HOYA
[2]HOYA Corporation: Historyhoya.com
Pentax merged into HOYA, adding medical endoscopy, imaging, and related optical technologies.
2007
Pentax became a consolidated subsidiary
[2]HOYA Corporation: Historyhoya.com
HOYA completed a friendly takeover bid and acquired control of Pentax.
2001
Soft intraocular lenses launched
[14]Eyeglass-lens production beganhoya.com
HOYA added soft intraocular lenses to its ophthalmic portfolio.
1991
Glass disks for hard-disk drives introduced
[14]Eyeglass-lens production beganhoya.com
The company began producing glass disks for hard-disk drives.
1987
Intraocular lenses and aspherical molding expanded
[14]Eyeglass-lens production beganhoya.com
HOYA launched intraocular lenses and began production of aspherical molded lenses.
1975
Semiconductor photomask blanks developed
[14]Eyeglass-lens production beganhoya.com
HOYA began producing photomask blanks for semiconductor manufacturing.
1972
Soft contact-lens production began
[14]Eyeglass-lens production beganhoya.com
HOYA expanded into soft contact lenses.
1962
Eyeglass-lens production began
[14]Eyeglass-lens production beganhoya.com
The company entered ophthalmic lenses for eyeglasses.
1961
Listed on the Tokyo Stock Exchange
[2]HOYA Corporation: Historyhoya.com
HOYA listed on the Second Section of the Tokyo Stock Exchange.
1945
Crystal products introduced
[2]HOYA Corporation: Historyhoya.com
HOYA expanded beyond optical glass by launching crystal products.
1944
Company incorporated
[1]HOYA Corporation: Corporate Profilehoya.com
The optical-glass operation was incorporated as a company in August 1944.
1941
Optical-glass business founded in Tokyo
[2]HOYA Corporation: Historyhoya.com
Shoichi and Shigeru Yamanaka established an optical-glass plant in Hoya, Tokyo, laying the foundation for the future HOYA group.

Products and positioning

A diversified, high-precision optical and healthcare technology group positioned around proprietary materials, optical engineering, advanced manufacturing, ophthalmic science, medical devices, and specialized business-to-business components. HOYA combines relatively stable Life Care demand with cyclical but high-value Information Technology businesses serving semiconductor and data-storage markets.

Life Care / Eye Health · 1962
Eyeglass lenses
HOYA manufactures prescription ophthalmic lenses spanning single-vision, progressive, high-index, photochromic, occupational, and specialty designs. The business applies the company's optical-design, resin, coating, molding, and precision-processing capabilities to produce lenses for vision correction and comfort. HOYA sells through professional optical channels and supports laboratories, distributors, and retail partners in multiple regions.
Life Care / Myopia management · 2018
MiYOSMART
MiYOSMART is a spectacle lens designed to manage the progression of childhood myopia. It uses Defocus Incorporated Multiple Segments technology, placing multiple treatment segments within the lens so that the wearer receives both central vision correction and a myopia-management optical profile. HOYA launched it in selected markets in 2018; regulatory approval and commercial availability differ by country. A later version is marketed as MiYOSMART iQ in some markets.
Life Care / Contact lenses
Contact lenses and Eyecity
HOYA's contact-lens activities include contact-lens products, private-label offerings, omnichannel sales, and the Eyecity specialist retail chain in Japan. The retail business serves consumers, particularly younger contact-lens users, through physical stores and online channels. HOYA has described the Japanese specialist retail channel as a major part of its contact-lens operations.
Life Care / Ophthalmic medical devices
Vivinex intraocular lenses
Vivinex is HOYA's intraocular-lens family for cataract surgery. The product platform combines a foldable intraocular-lens material intended to provide optical clarity with HOYA's multiSert injector system. The products are supplied primarily to hospitals, clinics, and ophthalmic surgeons and are sold internationally, with Japan representing an important market.
Life Care / Medical endoscopy · 2008
PENTAX Medical endoscopy systems
PENTAX Medical develops flexible reusable endoscopes, video processors, imaging systems, therapeutic accessories, and related services for gastrointestinal, ear-nose-and-throat, pulmonary, and other clinical applications. The business emphasizes image quality, practical workflow integration, ergonomics, cleanability, disinfection, and clinical support. It became part of HOYA through the Pentax merger and has been a central component of the group's medical strategy.
Information Technology / Semiconductor materials · 1975
Semiconductor photomask blanks and photomasks
HOYA supplies photomask blanks and photomasks used in semiconductor manufacturing. These precision optical materials form part of the lithography process through which circuit patterns are transferred to wafers. The business serves advanced semiconductor nodes and has benefited from demand for increasingly fine patterning, including applications associated with extreme ultraviolet lithography.
Information Technology / Data-storage components · 1991
Hard-disk-drive glass substrates
HOYA develops high-precision glass disks and substrates for hard-disk drives. These components require controlled flatness, smoothness, strength, and surface quality because they support the magnetic recording layers used in data-storage devices. The business is exposed to cyclical demand in storage hardware but remains part of HOYA's Information Technology portfolio and a focus area for capacity investment.
Software / Text-to-speech · 1999
ReadSpeaker voice-synthesis software
ReadSpeaker provided cloud-based text-to-speech software and services that converted written content into natural-sounding spoken output. Applications included web accessibility, education, public information, and audio content. HOYA acquired ReadSpeaker in 2017 but announced a transfer of the related voice-synthesis businesses in 2025 as part of a portfolio-resource-allocation decision.

Controversies

2025
Dispute over the use of a voice actor's recordings in the Iona AI voice
Voice actor Gayanne Potter alleged that a synthetic voice used by ScotRail and associated with ReadSpeaker was based on recordings she made in 2021 under terms she understood to be limited to accessibility and e-learning. The allegations raised questions about consent, contractual scope, voice identity, and the governance of synthetic voices.
Source
2024
Cyberattack and operational disruption
HOYA disclosed that a cyberattack detected on March 30, 2024 temporarily shut down systems supporting manufacturing, order processing, and other operations across multiple business units. The company said systems were restored and committed to a broad redesign of its cybersecurity infrastructure.
Source

2026
Launch a strategic review of the medical endoscope businessStrategy
Background
HOYA stated that it was reviewing its portfolio to improve long-term growth and capital efficiency and was assessing the strategic positioning of the global PENTAX Medical endoscope business.
Action taken
The board authorized a review of all strategic alternatives, including a possible transfer of the business to a third party.
Aftermath
As of the announcement, HOYA had made no decision regarding a transaction, timing, structure, method, or terms.
Source
2025
Adopt a progressive dividend policyStrategy
Background
HOYA reported investor requests for a clearer dividend policy and a higher payout orientation while retaining capital for research, capacity expansion, and acquisitions.
Action taken
The company adopted a progressive dividend policy with a target payout ratio of 40 percent and continued to preserve flexibility for share repurchases.
Aftermath
The policy rebalanced shareholder returns toward dividends while maintaining the company's broader capital-allocation framework.
Target dividend payout ratio. 40% (Announced May 2025)
Source
2025
Transfer the voice-synthesis businessM&A
Background
HOYA concluded that the voice-synthetic software business no longer represented the best allocation of group management resources despite achieving commercial traction.
Action taken
HOYA transferred the voice-synthesis business to ReadSpeaker Japan and transferred the related ReadSpeaker entities to a special-purpose company operated by Marunouchi Capital.
Aftermath
The transaction separated the business from HOYA's core portfolio; the announced impact on consolidated results was not expected to be material.
Source
2017
Acquire ReadSpeakerM&A
Background
HOYA sought to expand the international scale and language capabilities of its text-to-speech operations.
Action taken
HOYA acquired ReadSpeaker Holding B.V. and its subsidiaries.
Aftermath
ReadSpeaker became part of HOYA's speech-synthesis activities before those operations were transferred to a new owner in 2025.
Purchase price. (July 13, 2017)
Source
2007
Acquire and integrate PentaxM&A
Background
HOYA wanted to strengthen its medical business by adding Pentax's endoscopy, intraocular-lens, surgical, and related optical capabilities.
Action taken
HOYA completed a friendly takeover of Pentax in 2007, followed by the merger of Pentax into HOYA on March 31, 2008.
Aftermath
The transaction expanded HOYA's medical and optical portfolio, while the acquired surveying and camera businesses were later sold to Taiwan Instrument and Ricoh.
Source

Recent events

2020.11.23
Reported2020.11.23
Dispelix and Hoya announce AR/MR display partnership[18]Dispelix与Hoya宣布AR/MR显示领域合作prnewswire.com
Dispelix and Hoya announced a partnership under which Hoya will supply high-refractive-index glass wafers for Dispelix's single-layer and multi-layer diffractive AR waveguides for mass manufacturing.
2020.06.25
Reported2020.06.25
Cryosa raises $8.25 million in Series A-2 financing[19]Cryosa完成825万美元A-2轮融资tcbmag.com
Cryosa completed its Series A-2 financing round, raising $8.25 million. The company said the funding would be used to engage in first-in-human clinical trials.

Sources19 sources

Cite this profile: Cite the canonical profile. /brand-wiki/hoya · Editorial policy · How profiles are compiled